TLDR E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.
The E211 G>A Androgen Receptor Polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia, according to a study published in Cancer Epidemiology Biomarkers & Prevention in 2005. The study found that men with the E211 G>A polymorphism had a lower risk of developing metastatic prostate cancer and androgenetic alopecia compared to those without the polymorphism. The study included 1,056 men with prostate cancer and 1,267 controls. The study suggests that further investigation is needed to determine whether these associations can be attributed to linkage to one or both of the functional repeat sequences at the same loci.
50 citations
,
March 2001 in “Clinics in Dermatology” Genes and hormones cause hair loss, with four genes contributing equally.
299 citations
,
March 2001 in “Journal of Investigative Dermatology” 
179 citations
,
September 1998 in “BMJ” Hair loss in men is common, treatable, but not curable.
186 citations
,
July 1998 in “Journal of Cutaneous Medicine and Surgery” Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.
169 citations
,
June 1998 in “Journal of Investigative Dermatology” Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.
66 citations
,
January 2001 in “Vitamins and hormones” Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.
11 citations
,
March 2014 in “Journal of The European Academy of Dermatology and Venereology” Hair loss gene linked to prostate issues.
82 citations
,
April 2008 in “Journal of Investigative Dermatology” EDA2R gene linked to hair loss.
57 citations
,
November 2006 in “International Journal of Cancer” A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.
131 citations
,
September 2017 in “Molecular and Cellular Endocrinology” The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.
